|
| |
|
BC001111
Multiple organ normal and diseased tissue array, 58 cases/60 cores, replaced by MCN601
|
|
| Microarray Panel: | Multiple organ normal and diseased tissue microarray, single core per case, 10 types of tumor and normal organ (breast, colon, esophagus, kidney, liver, lung, ovary, rectum, stomach and uterine cervix) |
| Cores: | 60 |
|
| Cases: | 58 |
| Layout: | 9 cols × 7 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Cytokeratin (CK) confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bre - Breast,
Col - Colon,
Eso - Esophagus,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Ova - Ovary,
Rec - Rectum,
Sto - Stomach,
Ute - Uterine cervix
- Malignant tumor,
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
II |
Malignant |
|
A2 |
2 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
|
A3 |
3 |
F |
72 |
Esophagus |
Squamous cell carcinoma |
– |
Malignant |
|
A4 |
4 |
F |
55 |
Stomach |
Adenocarcinoma |
III |
Malignant |
|
A5 |
5 |
M |
56 |
Stomach |
Adenocarcinoma |
II |
Malignant |
|
A6 |
6 |
M |
74 |
Stomach |
Adenocarcinoma |
III |
Malignant |
|
A7 |
7 |
M |
37 |
Colon |
Adenocarcinoma |
– |
Malignant |
|
A8 |
8 |
M |
82 |
Colon |
Adenocarcinoma |
I |
Malignant |
|
A9 |
9 |
M |
58 |
Colon |
Adenocarcinoma |
I |
Malignant |
|
B1 |
10 |
M |
38 |
Esophagus |
Mucosa of esophagus |
– |
Normal |
|
B2 |
11 |
F |
72 |
Esophagus |
Mucosa of esophagus |
– |
Normal |
|
B3 |
12 |
M |
53 |
Esophagus |
Mucosa of esophagus |
– |
Normal |
|
B4 |
13 |
M |
54 |
Stomach |
Mucosa of stomach |
– |
Normal |
|
B5 |
14 |
M |
54 |
Stomach |
Mucosa of stomach |
– |
Normal |
|
B6 |
15 |
M |
66 |
Stomach |
Mucosa of stomach |
– |
Normal |
|
B7 |
16 |
F |
56 |
Colon |
Mucosa of colon |
– |
Normal |
|
B8 |
17 |
M |
62 |
Colon |
Mucosa of colon |
– |
Normal |
|
B9 |
18 |
M |
58 |
Colon |
Mucosa of colon |
– |
Normal |
|
C1 |
19 |
M |
55 |
Rectum |
Adenocarcinoma |
II |
Malignant |
|
C2 |
20 |
M |
67 |
Rectum |
Adenocarcinoma |
II |
Malignant |
|
C3 |
21 |
F |
55 |
Rectum |
Adenocarcinoma |
II |
Malignant |
|
C4 |
22 |
F |
32 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
|
C5 |
23 |
M |
39 |
Liver |
Hepatocellular carcinoma |
III |
Malignant |
|
C6 |
24 |
F |
55 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
|
C7 |
25 |
M |
66 |
Lung |
Squamous cell carcinoma |
II |
Malignant |
|
C8 |
26 |
F |
59 |
Lung |
Squamous cell carcinoma |
III |
Malignant |
|
C9 |
27 |
M |
55 |
Lung |
Chronic inflammation of lung |
– |
Malignant |
|
D1 |
28 |
F |
43 |
Rectum |
Mucosa of rectum |
– |
Normal |
|
D2 |
29 |
M |
33 |
Rectum |
Mucosa of rectum |
– |
Normal |
|
D3 |
30 |
M |
67 |
Rectum |
Mucosa of rectum |
– |
Normal |
|
D4 |
31 |
M |
63 |
Liver |
Liver tissue |
– |
Normal |
|
D5 |
32 |
F |
66 |
Liver |
Liver tissue |
– |
Normal |
|
D6 |
33 |
M |
48 |
Liver |
Liver tissue |
– |
Normal |
|
D7 |
34 |
M |
73 |
Lung |
Lung tissue |
– |
Normal |
|
D8 |
35 |
F |
68 |
Lung |
Lung tissue |
– |
Normal |
|
D9 |
36 |
M |
65 |
Lung |
Lung tissue |
– |
Normal |
|
E1 |
37 |
M |
72 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
|
E2 |
38 |
M |
50 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
|
E3 |
39 |
M |
54 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
|
E4 |
40 |
F |
29 |
Breast |
Intraductal carcinoma |
– |
Malignant |
|
E5 |
41 |
F |
45 |
Breast |
Infiltrating duct carcinoma |
– |
Malignant |
|
E6 |
42 |
F |
52 |
Breast |
Fatty tissue |
– |
Malignant |
|
E7 |
43 |
F |
76 |
Uterine cervix |
Squamous cell carcinoma |
II |
Malignant |
|
E8 |
44 |
F |
47 |
Uterine cervix |
Squamous cell carcinoma |
II |
Malignant |
|
E9 |
45 |
F |
42 |
Uterine cervix |
Squamous cell carcinoma |
III |
Malignant |
|
F1 |
46 |
M |
54 |
Kidney |
Kidney tissue |
– |
Normal |
|
F2 |
47 |
F |
61 |
Kidney |
Kidney tissue |
– |
Normal |
|
F3 |
48 |
F |
47 |
Kidney |
Kidney tissue |
– |
Normal |
|
F4 |
49 |
F |
43 |
Breast |
Breast tissue |
– |
Normal |
|
F5 |
50 |
F |
48 |
Breast |
Breast tissue |
– |
Normal |
|
F6 |
51 |
F |
41 |
Breast |
Breast tissue |
– |
Normal |
|
F7 |
52 |
F |
37 |
Breast |
Breast tissue |
– |
Normal |
|
F8 |
53 |
F |
50 |
Breast |
Breast tissue |
– |
Normal |
|
F9 |
54 |
F |
43 |
Breast |
Breast tissue |
– |
Normal |
|
G1 |
55 |
F |
56 |
Ovary |
Serous papillary adenocarcinoma |
III |
Malignant |
|
G2 |
56 |
F |
49 |
Ovary |
Serous papillary adenocarcinoma |
III |
Malignant |
|
G3 |
57 |
F |
39 |
Ovary |
Mucinous papillary adenocarcinoma |
I |
Malignant |
|
G4 |
58 |
F |
40 |
Ovary |
Ovary tissue |
– |
Normal |
|
G5 |
59 |
F |
39 |
Ovary |
Ovary tissue |
– |
Normal |
|
G6 |
60 |
F |
31 |
Ovary |
Ovary tissue |
– |
Normal |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|